|
C7ORF28B expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.69490018978536E-11 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.37570005071575E-09 |
| Normal-vs-Stage2 |
1.057170E-03 |
| Normal-vs-Stage3 |
6.643500E-03 |
| Normal-vs-Stage4 |
4.558100E-02 |
| Stage1-vs-Stage2 |
8.918600E-01 |
| Stage1-vs-Stage3 |
3.470000E-01 |
| Stage1-vs-Stage4 |
2.692400E-01 |
| Stage2-vs-Stage3 |
4.000800E-01 |
| Stage2-vs-Stage4 |
2.406400E-01 |
| Stage3-vs-Stage4 |
6.308200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.32159904820651E-11 |
| Normal-vs-AfricanAmerican |
6.18559999998602E-07 |
| Normal-vs-Asian |
3.808800E-01 |
| Caucasian-vs-AfricanAmerican |
6.954400E-01 |
| Caucasian-vs-Asian |
9.443800E-01 |
| AfricanAmerican-vs-Asian |
9.988400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.59590007875465E-10 |
| Normal-vs-Female |
3.03420000014043E-07 |
| Male-vs-Female |
9.532000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
8.29690000000438E-05 |
| Normal-vs-Extreme_Weight |
1.23719999800542E-08 |
| Normal-vs-Obese |
1.73459999996961E-06 |
| Normal-vs-Extreme_Obese |
1.467620E-01 |
| Normal_Weight-vs-Extreme_Weight |
3.139000E-01 |
| Normal_Weight-vs-Obese |
7.565200E-01 |
| Normal_Weight-vs-Extreme_Obese |
3.975600E-01 |
| Extreme_Weight-vs-Obese |
1.118010E-01 |
| Extreme_Weight-vs-Extreme_Obese |
1.900630E-01 |
| Obese-vs-Extreme_Obese |
4.060000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.436990E-04 |
| Normal-vs-Age(41-60Yrs) |
2.75629963297774E-10 |
| Normal-vs-Age(61-80Yrs) |
2.25980000267967E-08 |
| Normal-vs-Age(81-100Yrs) |
6.340000E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.566400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.729600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.169000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.529400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.879600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.480800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.64068758579106E-12 |
| Normal-VS-Type2 PRCC |
9.199900E-03 |
| Normal-VS-KIRP CIMP |
5.562500E-02 |
| Normal-VS-Unclassified PRCC |
1.246340E-04 |
| Type1 PRCC-VS-Type2 PRCC |
3.02819999997705E-06 |
| Type1 PRCC-VS-KIRP CIMP |
4.978500E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
9.496100E-02 |
| Type2 PRCC-VS-KIRP CIMP |
9.951400E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
5.980000E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
2.460400E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.588200E-04 |
| Normal-vs-N1 |
7.843900E-03 |
| Normal-vs-N2 |
6.741800E-01 |
| N0-vs-N1 |
5.427600E-01 |
| N0-vs-N2 |
1.982290E-02 |
| N1-vs-N2 |
3.213800E-01 |
|
|
